Jefferies on Protagonist Therapeutics (PTGX): 'well-funded for multiple high value oral peptide pipeline'
Go back to Jefferies on Protagonist Therapeutics (PTGX): 'well-funded for multiple high value oral peptide pipeline'| (NASDAQ: PTGX) | Delayed: 144.98 +1.98 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.00 | 52 Week High | $24.52 | |||
| Open | $143.22 | 52 Week Low | $10.02 | |||
| Day High | $145.37 | P/E | N/A | |||
| Day Low | $141.09 | EPS | $0.00 | |||
| Volume | 822,198 | |||||
